Aker BioMarine ASA (OSL:AKBM)
Norway · Delayed Price · Currency is NOK 110.00
+6.00 (5.77%)
Jul 31, 2026, 4:25 PM CET
Aker BioMarine ASA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 227.2 | 218.1 | 199 | 196.3 | 277.2 | 262.1 | |
Revenue Growth | 9.55% | 9.60% | 1.38% | -29.18% | 5.76% | -9.18% |
Cost of Revenue | 124.9 | 120.3 | 120.6 | 123.8 | 162.4 | 174 |
Gross Profit | 102.4 | 97.8 | 78.4 | 72.4 | 114.8 | 88.1 |
Selling, General & Admin | 70.3 | 69.1 | 68 | 66.4 | 86.5 | 85.7 |
Depreciation & Amortization Expenses | 18.2 | 18 | 16.6 | 16.3 | 16.4 | 19.2 |
Other Operating Expenses | -2.3 | -2 | -2.1 | 0.1 | -10.2 | -3.1 |
Total Operating Expenses | 86.2 | 85.1 | 82.5 | 82.8 | 92.7 | 101.8 |
Operating Income | 14.9 | 12.8 | -4.2 | -10.4 | 22.1 | -13.7 |
Interest Income | - | 0.9 | 4 | -1.5 | 4 | 21.3 |
Interest Expense | - | -17.5 | -10.9 | -19.7 | -22 | -15.7 |
Other Non-Operating Income (Expense) | -24.4 | 1.1 | -1 | -0.8 | 8.1 | 0.6 |
Total Non-Operating Income (Expense) | -24.4 | -15.5 | -7.9 | -22 | -9.9 | 6.2 |
Pretax Income | -9.5 | -2.8 | -12.1 | -32.3 | 12.2 | -7.4 |
Provision for Income Taxes | 0.5 | - | -0.1 | - | 2.2 | 0.6 |
Net Income | -10.1 | -2.8 | -12 | -32.3 | 10 | -8 |
Earnings From Discontinued Operations | -3.3 | -20 | 194.6 | 23.3 | - | - |
Net Income to Common | -13.4 | -22.8 | 182.6 | -9 | 10 | -8 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 103 | 88 | 88 | 88 | 88 | 88 |
Shares Outstanding (Diluted) | 103 | 88 | 88 | 88 | 88 | 88 |
Shares Change | 17.56% | 0.02% | 0.02% | 0.04% | 0.05% | 12.20% |
EPS (Basic) | -0.13 | -0.03 | -0.16 | -0.36 | 0.11 | -0.09 |
EPS (Diluted) | -0.13 | -0.03 | -0.16 | -0.36 | 0.11 | -0.09 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -5.9 | -2.1 | -5.2 | 1.5 | -25.4 | -76.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.06 | -0.02 | -0.06 | 0.02 | -0.29 | -0.87 |
Gross Margin | 45.07% | 44.84% | 39.40% | 36.88% | 41.41% | 33.61% |
Operating Margin | 6.56% | 5.87% | -2.11% | -5.30% | 7.97% | -5.23% |
Profit Margin | -4.45% | -1.28% | -6.03% | -16.45% | 3.61% | -3.05% |
FCF Margin | -2.60% | -0.96% | -2.61% | 0.76% | -9.16% | -29.03% |
EBITDA | 14.9 | 35.8 | 43.6 | 41.9 | 73.5 | 39.3 |
EBITDA Margin | 6.56% | 16.41% | 21.91% | 21.34% | 26.52% | 14.99% |
EBIT | 14.9 | 12.8 | -4.2 | -10.4 | 22.1 | -13.7 |
EBIT Margin | 6.56% | 5.87% | -2.11% | -5.30% | 7.97% | -5.23% |
Effective Tax Rate | -5.26% | 0.00% | 0.83% | 0.00% | 18.03% | -8.11% |